Cancer Research Cancer Medicine 8 Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, L.
Right arrow Articles by Morgan, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, L.
Right arrow Articles by Morgan, J. I.
[Cancer Research 63, 2733-2736, June 1, 2003]
© 2003 American Association for Cancer Research

Advances in Brief

Mouse Embryos Cloned from Brain Tumors1

Leyi Li, Michele C. Connelly, Cynthia Wetmore2, Tom Curran and James I. Morgan3

Department of Developmental Neurobiology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

Cancer cells escape from growth control by accumulating genetic and epigenetic alterations. In rare instances, epigenetic changes alone are oncogenic. Furthermore, agents that modify DNA methylation or chromatin structure can restore a normal phenotype to cells harboring oncogenic mutations. However, it is unclear to what extent epigenetic reprogramming can reverse oncogenesis. Using somatic nuclear transfer, we show that medulloblastomas arising in Ptc1+/- mice can direct preimplantation development. Additionally, blastocysts derived from medulloblastoma nuclei form postimplantation embryos with typical cell layers. Thus, tumor cells can be epigenetically reprogrammed into normal cell types. This approach could lead to a general strategy for assessing genetic and epigenetic contributions to tumorigenesis.




This article has been cited by other articles:


Home page
 DevelopmentHome page
K. Hochedlinger and K. Plath
Epigenetic reprogramming and induced pluripotency
Development, February 15, 2009; 136(4): 509 - 523.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J. D. Kessler, H. Hasegawa, S. N. Brun, B. A. Emmenegger, Z.-J. Yang, J. W. Dutton, F. Wang, and R. J. Wechsler-Reya
N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma
Genes & Dev., January 15, 2009; 23(2): 157 - 170.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
X. Fan and C. G. Eberhart
Medulloblastoma Stem Cells
J. Clin. Oncol., June 10, 2008; 26(17): 2821 - 2827.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Sasai, J. T. Romer, H. Kimura, D. E. Eberhart, D. S. Rice, and T. Curran
Medulloblastomas Derived from Cxcr6 Mutant Mice Respond to Treatment with a Smoothened Inhibitor
Cancer Res., April 15, 2007; 67(8): 3871 - 3877.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Sasai, J. T. Romer, Y. Lee, D. Finkelstein, C. Fuller, P. J. McKinnon, and T. Curran
Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies.
Cancer Res., April 15, 2006; 66(8): 4215 - 4222.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
K. Baverstock and O. V Belyakov
Classical radiation biology, the bystander effect and paradigms: a reply
Human and Experimental Toxicology, October 1, 2005; 24(10): 537 - 542.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
C. Hong, A. Maunakea, P. Jun, A. W. Bollen, J. G. Hodgson, D. D. Goldenberg, W. A. Weiss, and J. F. Costello
Shared Epigenetic Mechanisms in Human and Mouse Gliomas Inactivate Expression of the Growth Suppressor SLC5A8
Cancer Res., May 1, 2005; 65(9): 3617 - 3623.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
S. Wakayama, H. Ohta, S. Kishigami, N. Van Thuan, T. Hikichi, E. Mizutani, M. Miyake, and T. Wakayama
Establishment of Male and Female Nuclear Transfer Embryonic Stem Cell Lines from Different Mouse Strains and Tissues
Biol Reprod, April 1, 2005; 72(4): 932 - 936.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. H. Blelloch, K. Hochedlinger, Y. Yamada, C. Brennan, M. Kim, B. Mintz, L. Chin, and R. Jaenisch
Inaugural Article: Nuclear cloning of embryonal carcinoma cells
PNAS, September 28, 2004; 101(39): 13985 - 13990.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
K. Hochedlinger, R. Blelloch, C. Brennan, Y. Yamada, M. Kim, L. Chin, and R. Jaenisch
Reprogramming of a melanoma genome by nuclear transplantation
Genes & Dev., August 1, 2004; 18(15): 1875 - 1885.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
S.-C. Ng, N. Chen, W.-Y. Yip, S.-L. Liow, G.-Q. Tong, B. Martelli, L. G. Tan, and P. Martelli
The first cell cycle after transfer of somatic cell nuclei in a non-human primate
Development, May 15, 2004; 131(10): 2475 - 2484.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
R. JAENISCH, K. HOCHEDLINGER, R. BLELLOCH, Y. YAMADA, K. BALDWIN, and K. EGGAN
Nuclear Cloning, Epigenetic Reprogramming, and Cellular Differentiation
Cold Spring Harb Symp Quant Biol, January 1, 2004; 69(0): 19 - 28.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.